Loss of Fhit protein in carcinoma of primary and secondary müllerian systems [6]

Histopathology

Volumn 44, Issue 1, 2004, Pages 87-88

  Quddus, M R ^a   Sung, C J ^a   Cook, S W ^a   Wang, C ^a   Steinhoff, M M ^a   Hansen, K ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

CARCINOGENESIS; CARCINOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MUCINOUS CARCINOMA; MUELLERIAN DUCT; MUELLERIAN DUCT CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ACID ANHYDRIDE HYDROLASES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED TUMOR, MULLERIAN; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0842286955     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01747.x     Document Type: Letter

References (6)

1. Ohta M, Inoue H, Cotticelli MG et al. The FHIT gene spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers. Cell 1996: 84; 587-597.
2. Sozzi G, Veronese ML, Negrini M et al. The FHIT gene at 3p14.2 is abnormal in lung cancers. Cell 1996: 85; 1-26.
3. Virgilio L, Shuster M, Gollin SM et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 1996: 93; 9770-9775.
4. Eyzaguirre EJ, Miettinen M, Norris BA, Zoran G. Different immunohistochemical patterns of Fhit protein expression in renal neoplasm. Mod. Pathol. 1999: 12; 979-983.
5. Buttitta F, Marchetti A, Radi O et al. Evaluation of FHIT gene alterations in ovarian cancer. Br. J. Cancer 1998: 77; 1048-1051.
6. Hendricks DT, Taylor R, Reed M, Birrer MJ. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 1997: 57; 2112-2115.